REFERENCES
- Dini D, Forno G, Gozza A. Combined management in the treatment of epidoxorubicin extravasation. A case. Support Care Cancer 1995; 3(2)150–152
- Langer S W, Sehested M, Jensen P B. Treatment of anthracycline extravasation with dexrazoxane. Clin Cancer Research 2000; 6(9)3680–3686, [CSA]
- Askar I, Erbas M K, Gurlek A. Effects of heparin fraction on the prevention of skin necrosis resulting from extravasation: an experimental study. Ann Plast Surg 2002; 49(3)297–301, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Eroglu E, Sari A, Altuntas I. The effect of GM-CSF (granulocyte macrophage colony stimulating factor) on doxorrubicin induced tissue necrosis and wound healing. Indian J Cancer 2000; 37(4)153–157, [PUBMED], [INFOTRIEVE], [CSA]
- Langer S W, Sehested M, Jensen P B, et al. Dexrazoxane in Anthracycline extravasation. J.Clin.Oncol. 2000; 18(16)3064–3064, [PUBMED], [INFOTRIEVE], [CSA]
- Olver I N, Aisner J, Hament A. A prospective study of topical dimethyl sulfoxide for treating anthracycline extravasation. J Clin Oncol 1998; 6(11)1732–1735
- Ludwig C U, Stoll H R, Obrist R. Prevention of citotoxic drug induced skin ulcera with dimethyl sulfoxide (DMSO) and alpha-tocopherole. Eur J Cancer Clin Oncol 1987; 23(3)327–329, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Bertilli G, Gozza A, Forno G B. Topical dimethylsulfoxide for the prevention of soft tissue injury after extravasation of vesicant cytotoxic drugs: a prospective study. J Clin Oncol. 1995; 13(11)2851–2855
- Santos N C, Figueira Coelho J, Martins-Silva J. Multiddysciplinary utilization of dimethyl sulfoxide: pharmacological, cellular, and molecular aspects. Biochem Pharmacol. 2003; 65(7)1035–1041, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Dorr R, Alberts D, Chen H. The limited role of corticosteroids in ameliorating experimental doxorrubicin skin tocixity in the mouse. Cancer Chemother. Pharmacol 1980; 5: 17–20, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Creus N., Mateu J., Massó J. Toxicity to topical dimethyl sulfoxide (DMSO) when used as an extravasation antidote. Pharm World Sci 2002; 24(5)175–176, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]